Personalized genomics is a branch of genomics that is concerned with the analysis and sequencing of an individual’s genome. The genotype of an individual can be identified using various techniques such as next-generation sequencing (NGS), partial genome sequencing, single-nucleotide polymorphism (SNP) analysis, and full genome sequencing. After identifying an individual’s genotype, it is compared with published literature to determine trait expressions and the probability of acquiring certain diseases.
Personalized genomics play an imperative role in personalized and predictive medicine. With recent developments in gene sequencing techniques and data analytics, genetic testing technology is evolving rapidly. It is also expected that with the decreasing costs of genetic testing, personalized genomics is likely to become affordable for everyone in the near future, which will transform the genomics personalized health market into a highly lucrative business prospect.
Get Free PDF Brochure for more Professional and Technical industry insights: http://bit.ly/2cJvU1T
Some of the types of instruments generally used in personalized genomics are NGS platforms, RT-PCR, microarray, and sequencing and genetic analyzers. Some of the types of genetic tests used in personalized genomics are oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, and obstetrics testing.
A new market intelligence study by Transparency Market Research offers a comprehensive analysis of the genomics personalized health market across the globe. The report, titled “Genomics Personalized Health Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024,” presents insights into the latest trends, opportunities, and challenges within the market. The projected statistics and past performance of the global genomics personalized health market have been included in the research report.
The global market for genomics personalized health has been growing at a significant rate in the last few years. The expansion of application base of genomic research and testing is one of the key factors driving the global market. Additionally, technological developments in next-generation sequencing and whole genome and the rising consumer demand are expected to augment the growth of the market in the near future.
On the flip side, the declining average selling prices of genomics instruments and services, the time-consuming process of regulatory approvals, and the high cost of gene sequencing are the primary factors hampering the growth of the global genomics personalized health market. Nevertheless, the rising government investments in genetic research projects, favorable reimbursement models, and the adoption of improved regulatory policies are projected to encourage the growth of the global genomics personalized health market in the coming years.
By type of instrument, the global market for genomics personalized health has been divided into NGS platforms, sequencing and genetic analyzers, microarray, and RT-PCR. The key types of genetic tests used extensively in the global market include orphan disease testing, infectious disease testing, autoimmune disease testing, oncology testing, and obstetrics testing. The expected growth rate of each segment has been covered in the research report to offer a clear picture of the market.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/personalized-genomics-market.html
From the geographical perspective, North America currently accounts for a massive share of the global genomics personalized health market, due to the growing prevalence of cancer and other autoimmune diseases. Europe is expected to follow North America with an increased rate of adoption of genetic testing services. On the other hand, the Middle East, Asia Pacific, and Latin America are projected to experience substantial growth throughout the forecast period, due to the rising demand for research applications and advanced diagnostics solutions.
The genomics personalized health market across the globe is highly competitive in nature, thanks to the presence of several established players operating in the market. Some of the leading players in the global market are Genetic Technologies Group, Genelex Corporation, uBiome, Inc., Gene By Gene, LTD., Eastern Biotech & Life Sciences, Invitae, QIAGEN, Genotek, Indian Biosciences, Xcode Life Sciences, Roche Diagnostic, Knome, Inc., InoLife Technologies, Inc., Illumina, Inc., Life Technologies, Corp., Bio-Rad Laboratories, Inc., and Interleukin Genetics.